Logo

sequencing-based diagnostics

Clarified Precision Medicine Acquires Molecular Diagnostics Firm Interpares Biomedicine

The acquisition brings Interpares' genetic sequencing test, OncoGuardian, into Clarified's portfolio of precision medicine products.

Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development

The funds will help support Caris' ongoing commercial efforts in comprehensive cancer genomics as it makes new forays into liquid biopsy for multi-cancer early detection.

NantHealth Q1 Revenues Decline 11 Percent

NantHealth reported a net loss of $15.4 million during the quarter, as sequencing and molecular analysis revenues fell to just $3,000.

Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery
Premium

Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions.

Rare Disease Screening Firm 3billion Closes $13M Series C Financing

The Korean molecular diagnostics firm, a spinoff from genomic services provider Macrogen

Mar 24, 2021

Twist Bioscience, Biotia Nab FDA EUA for Hybridization-Based NGS SARS-CoV-2 Assay

Mar 16, 2021

Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China

Feb 25, 2021

NantHealth Q4 Revenues Flat From Year Ago

Feb 25, 2021

Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch
Premium

Feb 24, 2021

Adaptive Biotechnologies Q4 Revenues Rise 25 Percent

Feb 16, 2021

Fulgent Genetics, BioIQ Partner on NGS-Based SARS-CoV-2 Variant Detection

Feb 8, 2021

Illumina Adds Nine Startups to Accelerator Program, Announces £20M Matching Fund

Feb 2, 2021

Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing

Jan 21, 2021

Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test
Premium

Jan 14, 2021

Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan

Jan 11, 2021

Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan

Jan 7, 2021

Clear Labs, Integrated DNA Technologies Expand Partnership to Include COVID-19 Testing

Jan 5, 2021

Illumina, Helix Collaborate on CDC-Coordinated Coronavirus Surveillance

Dec 16, 2020

Illumina, Emedgene Partner on Automated Genomic Data Interpretation

Dec 8, 2020

Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing

Dec 3, 2020

Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing

Dec 2, 2020

China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis

Nov 24, 2020

Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform
Premium

Nov 18, 2020

Lurie Children's Hospital Details Migration of Clinical Diagnostics Lab to hg38 Reference Genome
Premium

Nov 11, 2020

Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test
Premium

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.